Viridian Therapeutics Inc...

NASDAQ: VRDN · Real-Time Price · USD
18.53
0.09 (0.49%)
At close: Aug 15, 2025, 3:59 PM
18.50
-0.16%
After-hours: Aug 15, 2025, 07:26 PM EDT

Viridian Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.82 -4.1 -7.47 -2.97
PEG Ratio
0.19 -0.11 0.18 0.04
PS Ratio
4.31K 3.1K 528.93 79.53
PB Ratio
1.94 2.21 2.37 1.26
P/FCF Ratio
-5.59 -5.27 -9.9 -4.29
P/OCF Ratio
-5.6 -5.29 -9.99 -4.32
OCF/S Ratio
-769.27 -586.53 -52.96 -18.42
Debt / Equity Ratio
0.03 0.05 0.01 0.00
Quick Ratio
15.43 18.26 12.93 14.68
Current Ratio
15.43 18.26 12.73 14.68
Asset Turnover
0.00 0.00 0.00 0.01
Interest Coverage
-98.17 -137.76 -276.35 -26.58K
Return on Equity
-0.4 -0.54 -0.32 -0.42
Return on Assets
-0.36 -0.48 -0.29 -0.39
Return on Invested Capital
-0.43 -0.55 -0.32 -0.42
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -3.21 0.57 0.79
Net Profit Margin
-893.87 -757.11 -70.79 -26.8
Pretax Profit Margin
-893.87 -757.11 -73.29 -26.8
Operating Profit Margin
-990.18 -810.35 -75.79 -26.91
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-879.68 -747.02 -72.59 -26.59